3Bartley GB,Gorman CA.Diagnostic criteria for Graves' ophthalmopathy[J].Am J Ophthalmol,1995,119(6):792-795.
4International ad hoc Committee.Classification of eye changes of Graves' disease[J].Thyroid,1992,2(3):235-236.
5Bartalena L,Tanda ML.Graves' ophthalmopathy[J].N Eng J Med,2009,360(10):994-1001.
6Salvi M,Vannucchi G,Campi I,et al.Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab:an open study[J].Eur J Endocrinol,2007,156(1):33-40.
7Paridaens D,Vanden Bosch WA,Vander Loos TL,et al.The effect of etanercept on Graves' ophthalmopathy:a pilot study[J].Eye,2005,19(12):1286-1289.
8Morgenthaler NG, Hodak K, Seissler J, et al.Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay[J].Thyroid,1999, 9(5): 466-475.
9Patibandla SA, Prabhakar BS.Autoimmunity to the thyroid stimulating hormone receptor[J]. Adv Neuroimmunol, 1996, 6(4): 347-357.
10Bogner U, Hegedus L, Hansen JM, et al.Thyroid cytotoxic antibodies in atrophic and goitrous autoimmune thyroiditis[J]. Eur J Endocrinol,1995,132:69-74.
